Finance

Lists
N6B:FRA
Labcorp Holdings Inc
€284.00
+0.71%
(+2.00) 1D
Aug 24, 8:09:49 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for N6B...
Open
€284.00
High
€284.00
Low
€284.00
Mkt. cap
27.37B
Avg. vol.
12.00
Volume
0.00
52-wk high
€284.00
52-wk low
€212.00
No. of employees
71K
Open
€284.00
High
€284.00
Low
€284.00
Mkt. cap
27.37B
Avg. vol.
12.00
Volume
0.00
52-wk high
€284.00
52-wk low
€212.00
No. of employees
71K
News stories
From web sources and news partners
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees71K
Founded1978
HeadquartersBurlington, North Carolina, United States
SectorHealth care provider
Websitelabcorp.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.56B
3.52B
3.54B
3.73B
Cost of goods sold
2.54B
2.52B
2.52B
2.62B
Cost of revenue
2.54B
2.52B
2.52B
2.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
552.40M
549.70M
551.00M
577.20M
Operating expense
621.90M
622.30M
626.60M
655.30M
Total operating expenses
3.16B
3.14B
3.15B
3.27B
Operating income
403.20M
370.90M
387.20M
456.70M
Other non operating income
700.00K
1.90M
-600.00K
-3.50M
EBT including unusual items
337.00M
190.60M
319.70M
386.40M
EBT excluding unusual items
341.30M
315.20M
333.20M
391.50M
Income tax expense
75.50M
25.70M
41.70M
87.30M
Effective tax rate
22.40%
13.48%
13.04%
22.59%
Other operating expenses
-
-
-
-
Net income
261.10M
164.70M
277.80M
298.70M
Net profit margin
7.33%
4.68%
7.85%
8.01%
Earnings per share
4.18
4.07
4.25
4.99
Interest and investment income
3.50M
3.50M
12.20M
5.60M
Interest expense
-56.00M
-55.00M
-55.10M
-61.10M
Net interest expenses
-52.50M
-51.50M
-42.90M
-55.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
574.20M
549.40M
560.50M
635.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps